Viridien
Short position disclosed on August 12, 2026.
5.32% of the capital sold short
7 disclosing funds
2,460 disclosures on record
Evolution of the disclosed total
0%2%4%6%
Oct 2025Jan 2026Apr 2026Jul 2026
January 7, 2013 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Capital Fund Management | 1.59% | +0.50 pt | July 31, 2026 | |
| Marshall Wace LLP | 0.80% | -0.39 pt | August 7, 2026 | |
| TWO Sigma Investments, LP | 0.64% | new | August 3, 2026 | |
| Citadel Advisors LLC | 0.61% | +0.01 pt | August 12, 2026 | |
| Walleye Capital LLC | 0.60% | new | August 7, 2026 | |
| Mirabella Financial Services LLP | 0.57% | unchanged | January 30, 2025 | |
| Tudor Capital Europe LLP | 0.51% | new | May 7, 2026 |
On the other side: the funds that hold Viridien Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 9, 2024 | Millennium International Management LP | 0.69% | January 24, 2024 |
| January 9, 2024 | Millennium Capital Management France | 0.58% | January 16, 2024 |
| January 8, 2024 | Qube Research & Technologies Limited | 0.95% | March 4, 2024 |
| January 4, 2024 | Marshall Wace LLP | 2.13% | March 24, 2025 |
| January 4, 2024 | Qube Research & Technologies Limited | 0.86% | March 4, 2024 |
| January 3, 2024 | Qube Research & Technologies Limited | 0.93% | March 4, 2024 |
| January 2, 2024 | Qube Research & Technologies Limited | 0.88% | March 4, 2024 |
| December 29, 2023 | Qube Research & Technologies Limited | 0.99% | March 4, 2024 |
| December 28, 2023 | Qube Research & Technologies Limited | 1.00% | March 4, 2024 |
| December 27, 2023 | Marshall Wace LLP | 2.29% | March 24, 2025 |
| December 27, 2023 | Qube Research & Technologies Limited | 0.95% | March 4, 2024 |
| December 22, 2023 | Marshall Wace LLP | 2.39% | March 24, 2025 |
| December 22, 2023 | Qube Research & Technologies Limited | 1.01% | March 4, 2024 |
| December 21, 2023 | Qube Research & Technologies Limited | 1.20% | March 4, 2024 |
| December 20, 2023 | Marshall Wace LLP | 2.49% | March 24, 2025 |
| December 19, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 |
| December 18, 2023 | Marshall Wace LLP | 2.50% | March 24, 2025 |
| December 18, 2023 | Qube Research & Technologies Limited | 1.43% | March 4, 2024 |
| December 15, 2023 | Qube Research & Technologies Limited | 1.38% | March 4, 2024 |
| December 14, 2023 | Marshall Wace LLP | 2.45% | March 24, 2025 |
| December 14, 2023 | Qube Research & Technologies Limited | 1.47% | March 4, 2024 |
| December 13, 2023 | Marshall Wace LLP | 2.37% | March 24, 2025 |
| December 11, 2023 | Qube Research & Technologies Limited | 1.14% | March 4, 2024 |
| December 8, 2023 | Marshall Wace LLP | 2.21% | March 24, 2025 |
| December 8, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 |
| December 7, 2023 | Marshall Wace LLP | 2.14% | March 24, 2025 |
| December 7, 2023 | Millennium Capital Management France | 0.49% | December 11, 2023 |
| December 6, 2023 | Qube Research & Technologies Limited | 0.75% | March 4, 2024 |
| December 6, 2023 | Millennium Capital Management France | 0.61% | December 11, 2023 |
| December 5, 2023 | Qube Research & Technologies Limited | 0.96% | March 4, 2024 |
| December 5, 2023 | Millennium Capital Management France | 0.53% | December 11, 2023 |
| December 4, 2023 | Qube Research & Technologies Limited | 1.10% | March 4, 2024 |
| December 1, 2023 | Qube Research & Technologies Limited | 1.08% | March 4, 2024 |
| November 30, 2023 | Qube Research & Technologies Limited | 1.17% | March 4, 2024 |
| November 29, 2023 | Qube Research & Technologies Limited | 1.26% | March 4, 2024 |
| November 28, 2023 | Qube Research & Technologies Limited | 1.31% | March 4, 2024 |
| November 24, 2023 | Qube Research & Technologies Limited | 1.25% | March 4, 2024 |
| November 22, 2023 | Marshall Wace LLP | 2.08% | March 24, 2025 |
| November 22, 2023 | Qube Research & Technologies Limited | 1.35% | March 4, 2024 |
| November 21, 2023 | Qube Research & Technologies Limited | 1.17% | March 4, 2024 |
| November 20, 2023 | Qube Research & Technologies Limited | 1.02% | March 4, 2024 |
| November 17, 2023 | Qube Research & Technologies Limited | 1.12% | March 4, 2024 |
| November 16, 2023 | Marshall Wace LLP | 2.13% | March 24, 2025 |
| November 16, 2023 | Qube Research & Technologies Limited | 1.20% | March 4, 2024 |
| November 15, 2023 | Qube Research & Technologies Limited | 1.05% | March 4, 2024 |
| November 14, 2023 | Marshall Wace LLP | 2.05% | March 24, 2025 |
| November 14, 2023 | Qube Research & Technologies Limited | 1.11% | March 4, 2024 |
| November 14, 2023 | ActusRayPartners Limited | 0.47% | November 16, 2023 |
| November 13, 2023 | Qube Research & Technologies Limited | 1.27% | March 4, 2024 |
| November 9, 2023 | Qube Research & Technologies Limited | 1.19% | March 4, 2024 |
Other companies sold short in France
- Ubisoft Entertainment 13.69% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- FDJ United 6.67% of the capital sold short
- Renault 6.54% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
- Publicis Groupe SA 3.38% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Viridien, source AMF, data as at August 12, 2026, https://www.quivad.com/action/viridien?page=10